Medical - Devices
Compare Stocks
5 / 10Stock Comparison
TCMD vs LNTH vs ITGR vs MMSI vs CNMD
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
Medical - Devices
Medical - Instruments & Supplies
Medical - Devices
TCMD vs LNTH vs ITGR vs MMSI vs CNMD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Devices | Drug Manufacturers - Specialty & Generic | Medical - Devices | Medical - Instruments & Supplies | Medical - Devices |
| Market Cap | $587M | $5.92B | $3.03B | $3.72B | $1.17B |
| Revenue (TTM) | $344M | $1.55B | $1.85B | $1.54B | $1.37B |
| Net Income (TTM) | $20M | $279M | $142M | $139M | $55M |
| Gross Margin | 75.7% | 60.5% | 23.3% | 48.7% | 53.6% |
| Operating Margin | 9.4% | 18.8% | 10.4% | 12.2% | 11.3% |
| Forward P/E | 22.8x | 17.5x | 13.5x | 15.5x | 8.7x |
| Total Debt | $16M | $738K | $1.40B | $898M | $835M |
| Cash & Equiv. | $83M | $359M | $17M | $449M | $41M |
TCMD vs LNTH vs ITGR vs MMSI vs CNMD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Tactile Systems Tec… (TCMD) | 100 | 53.7 | -46.3% |
| Lantheus Holdings, … (LNTH) | 100 | 662.8 | +562.8% |
| Integer Holdings Co… (ITGR) | 100 | 111.0 | +11.0% |
| Merit Medical Syste… (MMSI) | 100 | 138.5 | +38.5% |
| CONMED Corporation (CNMD) | 100 | 51.9 | -48.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TCMD vs LNTH vs ITGR vs MMSI vs CNMD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TCMD is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 12.5%, EPS growth 17.1%, 3Y rev CAGR 10.1%
- 12.5% revenue growth vs LNTH's 0.5%
- +169.8% vs MMSI's -33.8%
LNTH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.47
- 41.9% 10Y total return vs MMSI's 214.6%
- Lower volatility, beta 0.47, Low D/E 0.1%, current ratio 2.70x
- 18.0% margin vs CNMD's 4.0%
ITGR lags the leaders in this set but could rank higher in a more targeted comparison.
MMSI is the clearest fit if your priority is defensive.
- Beta 0.71, current ratio 4.34x
CNMD ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.24 vs ITGR's 3.08
- Lower P/E (8.7x vs 15.5x)
- 2.1% yield; 2-year raise streak; the other 4 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.5% revenue growth vs LNTH's 0.5% | |
| Value | Lower P/E (8.7x vs 15.5x) | |
| Quality / Margins | 18.0% margin vs CNMD's 4.0% | |
| Stability / Safety | Beta 0.47 vs CNMD's 1.34, lower leverage | |
| Dividends | 2.1% yield; 2-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +169.8% vs MMSI's -33.8% | |
| Efficiency (ROA) | 12.4% ROA vs CNMD's 2.4%, ROIC 30.6% vs 5.8% |
TCMD vs LNTH vs ITGR vs MMSI vs CNMD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TCMD vs LNTH vs ITGR vs MMSI vs CNMD — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LNTH leads in 3 of 6 categories
CNMD leads 2 • TCMD leads 0 • ITGR leads 0 • MMSI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LNTH leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ITGR is the larger business by revenue, generating $1.8B annually — 5.4x TCMD's $344M. LNTH is the more profitable business, keeping 18.0% of every revenue dollar as net income compared to CNMD's 4.0%. On growth, TCMD holds the edge at +22.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $344M | $1.5B | $1.8B | $1.5B | $1.4B |
| EBITDAEarnings before interest/tax | $39M | $347M | $328M | $290M | $219M |
| Net IncomeAfter-tax profit | $20M | $279M | $142M | $139M | $55M |
| Free Cash FlowCash after capex | $39M | $372M | $168M | $274M | $124M |
| Gross MarginGross profit ÷ Revenue | +75.7% | +60.5% | +23.3% | +48.7% | +53.6% |
| Operating MarginEBIT ÷ Revenue | +9.4% | +18.8% | +10.4% | +12.2% | +11.3% |
| Net MarginNet income ÷ Revenue | +5.9% | +18.0% | +7.7% | +9.0% | +4.0% |
| FCF MarginFCF ÷ Revenue | +11.4% | +24.0% | +9.1% | +17.8% | +9.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +22.8% | +1.2% | +0.8% | +7.8% | -0.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +38.5% | +76.5% | +172.7% | +38.8% | +136.8% |
Valuation Metrics
CNMD leads this category, winning 7 of 7 comparable metrics.
Valuation Metrics
At 25.2x trailing earnings, CNMD trades at a 20% valuation discount to TCMD's 31.7x P/E. Adjusting for growth (PEG ratio), CNMD offers better value at 0.69x vs ITGR's 6.91x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $587M | $5.9B | $3.0B | $3.7B | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $519M | $5.6B | $4.4B | $4.2B | $2.0B |
| Trailing P/EPrice ÷ TTM EPS | 31.72x | 26.69x | 30.42x | 29.26x | 25.22x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.82x | 17.52x | 13.55x | 15.46x | 8.71x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 6.91x | — | 0.69x |
| EV / EBITDAEnterprise value multiple | 14.45x | 14.61x | 13.15x | 13.06x | 10.17x |
| Price / SalesMarket cap ÷ Revenue | 1.78x | 3.84x | 1.64x | 2.45x | 0.85x |
| Price / BookPrice ÷ Book value/share | 2.77x | 5.72x | 1.79x | 2.38x | 1.15x |
| Price / FCFMarket cap ÷ FCF | 14.51x | 16.73x | 28.78x | 17.24x | 7.78x |
Profitability & Efficiency
LNTH leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
LNTH delivers a 24.3% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $5 for CNMD. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CNMD's 0.81x. On the Piotroski fundamental quality scale (0–9), TCMD scores 8/9 vs CNMD's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.7% | +24.3% | +8.2% | +8.9% | +5.4% |
| ROA (TTM)Return on assets | +7.5% | +12.4% | +4.2% | +5.2% | +2.4% |
| ROICReturn on invested capital | +13.8% | +30.6% | +5.4% | +7.2% | +5.8% |
| ROCEReturn on capital employed | +11.9% | +17.1% | +6.9% | +7.9% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.07x | 0.00x | 0.80x | 0.57x | 0.81x |
| Net DebtTotal debt minus cash | -$67M | -$358M | $1.4B | $450M | $794M |
| Cash & Equiv.Liquid assets | $83M | $359M | $17M | $449M | $41M |
| Total DebtShort + long-term debt | $16M | $738,000 | $1.4B | $898M | $835M |
| Interest CoverageEBIT ÷ Interest expense | 76.34x | 11.72x | 5.07x | 10.74x | 5.20x |
Total Returns (Dividends Reinvested)
Evenly matched — TCMD and LNTH each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LNTH five years ago would be worth $41,420 today (with dividends reinvested), compared to $2,902 for CNMD. Over the past 12 months, TCMD leads with a +169.8% total return vs MMSI's -33.8%. The 3-year compound annual growth rate (CAGR) favors TCMD at 11.5% vs CNMD's -31.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -5.1% | +35.3% | +14.5% | -27.9% | -6.0% |
| 1-Year ReturnPast 12 months | +169.8% | +13.1% | -26.1% | -33.8% | -31.3% |
| 3-Year ReturnCumulative with dividends | +38.8% | -4.0% | +8.8% | -26.5% | -67.3% |
| 5-Year ReturnCumulative with dividends | -53.5% | +314.2% | -7.5% | -3.6% | -71.0% |
| 10-Year ReturnCumulative with dividends | +134.7% | +4192.5% | +165.1% | +214.6% | +6.6% |
| CAGR (3Y)Annualised 3-year return | +11.5% | -1.4% | +2.9% | -9.8% | -31.1% |
Risk & Volatility
LNTH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LNTH is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than CNMD's 1.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNTH currently trades 97.8% from its 52-week high vs MMSI's 62.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.99x | 0.47x | 0.72x | 0.71x | 1.34x |
| 52-Week HighHighest price in past year | $37.75 | $93.00 | $123.78 | $100.19 | $61.08 |
| 52-Week LowLowest price in past year | $9.34 | $47.25 | $62.00 | $59.74 | $33.21 |
| % of 52W HighCurrent price vs 52-week peak | +68.9% | +97.8% | +71.0% | +62.2% | +62.4% |
| RSI (14)Momentum oscillator 0–100 | 53.9 | 61.2 | 50.9 | 34.9 | 49.6 |
| Avg Volume (50D)Average daily shares traded | 279K | 886K | 628K | 769K | 406K |
Analyst Outlook
CNMD leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: TCMD as "Buy", LNTH as "Buy", ITGR as "Buy", MMSI as "Buy", CNMD as "Hold". Consensus price targets imply 104.8% upside for CNMD (target: $78) vs 11.0% for LNTH (target: $101). CNMD is the only dividend payer here at 2.09% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $38.75 | $101.00 | $98.00 | $95.00 | $78.00 |
| # AnalystsCovering analysts | 11 | 17 | 14 | 13 | 21 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +2.1% |
| Dividend StreakConsecutive years of raises | 1 | 0 | — | — | 2 |
| Dividend / ShareAnnual DPS | — | — | — | — | $0.79 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.5% | +5.1% | +1.7% | 0.0% | 0.0% |
LNTH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNMD leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
TCMD vs LNTH vs ITGR vs MMSI vs CNMD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TCMD or LNTH or ITGR or MMSI or CNMD a better buy right now?
For growth investors, Tactile Systems Technology, Inc.
(TCMD) is the stronger pick with 12. 5% revenue growth year-over-year, versus 0. 5% for Lantheus Holdings, Inc. (LNTH). CONMED Corporation (CNMD) offers the better valuation at 25. 2x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Tactile Systems Technology, Inc. (TCMD) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TCMD or LNTH or ITGR or MMSI or CNMD?
On trailing P/E, CONMED Corporation (CNMD) is the cheapest at 25.
2x versus Tactile Systems Technology, Inc. at 31. 7x. On forward P/E, CONMED Corporation is actually cheaper at 8. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CONMED Corporation wins at 0. 24x versus Integer Holdings Corporation's 3. 08x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — TCMD or LNTH or ITGR or MMSI or CNMD?
Over the past 5 years, Lantheus Holdings, Inc.
(LNTH) delivered a total return of +314. 2%, compared to -71. 0% for CONMED Corporation (CNMD). Over 10 years, the gap is even starker: LNTH returned +41. 9% versus CNMD's +6. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TCMD or LNTH or ITGR or MMSI or CNMD?
By beta (market sensitivity over 5 years), Lantheus Holdings, Inc.
(LNTH) is the lower-risk stock at 0. 47β versus CONMED Corporation's 1. 34β — meaning CNMD is approximately 185% more volatile than LNTH relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 81% for CONMED Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — TCMD or LNTH or ITGR or MMSI or CNMD?
By revenue growth (latest reported year), Tactile Systems Technology, Inc.
(TCMD) is pulling ahead at 12. 5% versus 0. 5% for Lantheus Holdings, Inc. (LNTH). On earnings-per-share growth, the picture is similar: Tactile Systems Technology, Inc. grew EPS 17. 1% year-over-year, compared to -64. 6% for CONMED Corporation. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TCMD or LNTH or ITGR or MMSI or CNMD?
Lantheus Holdings, Inc.
(LNTH) is the more profitable company, earning 15. 2% net margin versus 3. 4% for CONMED Corporation — meaning it keeps 15. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LNTH leads at 20. 2% versus 8. 9% for TCMD. At the gross margin level — before operating expenses — TCMD leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TCMD or LNTH or ITGR or MMSI or CNMD more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CONMED Corporation (CNMD) is the more undervalued stock at a PEG of 0. 24x versus Integer Holdings Corporation's 3. 08x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, CONMED Corporation (CNMD) trades at 8. 7x forward P/E versus 22. 8x for Tactile Systems Technology, Inc. — 14. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNMD: 104. 8% to $78. 00.
08Which pays a better dividend — TCMD or LNTH or ITGR or MMSI or CNMD?
In this comparison, CNMD (2.
1% yield) pays a dividend. TCMD, LNTH, ITGR, MMSI do not pay a meaningful dividend and should not be held primarily for income.
09Is TCMD or LNTH or ITGR or MMSI or CNMD better for a retirement portfolio?
For long-horizon retirement investors, Lantheus Holdings, Inc.
(LNTH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 47)). Both have compounded well over 10 years (LNTH: +41. 9%, TCMD: +134. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TCMD and LNTH and ITGR and MMSI and CNMD?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
CNMD pays a dividend while TCMD, LNTH, ITGR, MMSI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.